MeSH tree: C06.552
The U.S. Food and Drug Administration has approved Hepcludex (bulevirtide‐gmod) injection to treat chronic hepatitis delta virus (HDV) infection in adults without cirrhosis or compensated cirrhosis. Approval of Hepcludex ...
Jun 5, 2026
0
3
In a study published in the Liver Transplantation journal, Mayo Clinic researchers have found that a new proactive treatment protocol for alcohol use disorder after liver transplant resulted in a 0% heavy alcohol relapse ...
Jun 3, 2026
2
3
A new UC San Francisco study reveals how Philip Morris Companies Inc. used cigarette research, flavor engineering, and behavioral science to turn Lunchables into one of America's most successful ultra-processed foods for ...
Jun 3, 2026
0
7
Researchers at the University of Massachusetts Amherst have designed non-toxic Salmonella bacteria to deliver viruses that are safe to humans but potent against liver and pancreatic cancer tumors—two cancers with an extremely ...
Jun 3, 2026
0
6
Different types of liver disease are leading to distinct signatures of muscle loss, according to a new study that could help pave the way for more personalized treatments for sarcopenia in people with end-stage liver disease. ...
Jun 1, 2026
0
2
In Las Vegas May 2026, athletes compete in an international sporting event that explicitly allows them to use performance-enhancing drugs (PEDs). The Enhanced Games openly encourages competitors to use substances banned in ...
Jun 1, 2026
0
1
In 1959, a young doctor named David Sackett stumbled on a clinical trial that would change his life—and most of ours. The study showed that conventional wisdom on bed rest in medicine was wrong. And it helped lead Sackett ...
May 30, 2026
0
10
In an editorial published in the New England Journal of Medicine, University of Michigan Health hepatologist Anna S. Lok, M.D., hails newly announced results of the B-Well clinical trials as "a major step toward a functional ...
May 29, 2026
0
13
National Taiwan University Hospital (NTUH), in collaboration with multiple medical centers across Taiwan, has found that patients with hepatitis C remain at a significantly elevated risk of hepatocellular carcinoma (HCC) ...
May 26, 2026
0
2
A new type of cell therapy shows promise as the first treatment for advanced liver disease, following results from a clinical trial. Patients with the condition who were treated with the cell therapy had a significantly lower ...
May 25, 2026
0
8
